Calendar

««Mar 2010»»
SMTWTFS
  123456
78910111213
14151617181920
21222324252627
28293031
  More

Search Box

 

cbt and mindfulness

Mailing List

RSS Feeds








Add to Jamespot
Widgetize!

Translate

Disclaimer

All content within Anxiety Insights is provided for general information only, and should not be treated as a substitute for the medical advice of your doctor or other health care professional.

Anxiety Insights is not responsible or liable for any diagnosis made by a reader based on the content of this website.

Anxiety Insights is not liable for the contents of any external internet sites listed, nor does it endorse any commercial product or service mentioned or advised on any of the sites.

Always consult your doctor if you are in any way concerned about your health.

Recommended links

Depression is Real's Down & Up Show
Weekly audio-casts from the Depression Is Real Coalition

Teen Drug Abuse Intervention
Help fight teen drug abuse, we provide information to help fight teen drug abuse by prevention and intervention.
www.teendrugabuse.us


we support

Kiva.org - micro loans that change lives

Moving a Nation to Care : Post Traumatic Stress Disorder and America's Returning Troops, by Ilona Meagher

No Longer Lonely.com

"just don't smoke"


"Don't smoke, whatever you do, just don't smoke."
                        Yul Brynner

Hit Counter

Total: 3,605,108
since: 14 May 2006

NICE Guidelines: UK docs told to hold antidepressants for teens

posted Thursday, 29 September 2005

Latest NICE guidance sets new standards for treating depression in children and young people

The National Institute for Health and Clinical Excellence (NICE) and the National Collaborating Centre for Mental Health have today (28th September) launched a clinical guideline on the treatment and management of depression in children and young people. The guideline recommends that:
  • Children and young people with moderate to severe depression should be offered, as a first-line treatment, a specific psychological therapy (such as cognitive behavioural therapy, interpersonal therapy or family therapy of at least 3 months' duration).
  • Antidepressant medication should not be offered to children or young people with moderate to severe depression except in combination with a concurrent psychological therapy and should not be offered at all to children with mild depression.
  • Healthcare professionals in primary care, schools and other relevant community settings should be trained to detect symptoms of depression, and to assess children and young people who may be at risk of depression.
  • Attention should be paid to the possible need for parents' own psychiatric problems (particularly depression) to be treated in parallel, if the child or young person's mental health is to improve.
Andrew Dillon, Chief Executive of NICE and Executive Lead for this guideline says "This guideline makes it clear that psychological treatments are the most effective way to treat depression in children and young people. It's important that children and young people taking anti-depressants do not stop taking them abruptly, but we would advise people to talk to their GP at their next regular review about whether a psychological treatment may be a more effective treatment option."

Dr Tim Kendall, Joint Director of the National Collaborating Centre for Mental Health who developed the guideline on behalf of NICE says "This is the sixth mental health guideline where we have recommended psychological treatments as key treatments for a mental health condition and the third where we have recommended them as the first line treatment. The evidence supporting these treatments is robust and it is vital that the NHS provides psychological therapies to ensure everyone who needs these treatments can access them rapidly."

Professor Peter Fonagy, Professor of Psychoanalysis and Chair, Guideline Development Group says "Depression in children is more common than many people realise and often goes unrecognised. Around 1% of children and 3% of adolescents will suffer from depression in any one year. It can severely impact on school performance, self esteem and making and retaining friendships. It can lead to a greatly increased risk of mental health problems in adult life and at its most serious it can dramatically increase the lifetime risk of suicide, from 1.3% in the general population to 6%."

Ms Charlotte Dodds, Depression Support Group Co-Facilitator and Carer Representative on the Guideline Development Group says "Depression disproportionately affects the most disadvantaged children. Children and young people with emotional disorders, when compared with children without a mental disorder, were nearly twice as likely to be living with a lone parent (28% versus 15%), more than twice as likely to be with both parents being unemployed (27% versus 12%), and more likely to have parents who were on low incomes, had fewer qualifications and living in social sector housing. I hope this guideline raises awareness of the issue and encourages more equal access to treatments for all children and young people with depression, no matter where or how they live."

Ms Dinah Morley, Deputy Director of YoungMinds says "YoungMinds welcomes the emphasis on psychological therapies as the best approach to the treatment of depression. However the very significant shortage of practitioners able to deliver these therapies is a cause for concern, as is the general lack of awareness of the prevalence of depression in babies, children and young people. We look to increasing investment in services which support the mental health of children and young people and to improvements in the training of all practitioners working with children, to help them in identifying symptoms of depression and in seeking effective help. Too many children's lives are blighted by depression, a condition for which there are effective treatments. We welcome the NICE guidelines as another reminder that children's mental health matters and is the business of everybody."

The Committee on the Safety of Medicines issued advice on the safety of antidepressant medication for children in 2003. The NICE guidance complements and builds on this advice.


On 1 April 2005 the National Institute for Clinical Excellence took on the functions of the Health Development Agency to form the National Institute for Health and Clinical Excellence (NICE). NICE is the independent organisation responsible for providing national guidance on the promotion of good health and the prevention and treatment of ill health.



CG28 Depression in children and young people - Information for the public   (PDF   1.1MB)

CG28 Depression in children and young people - Quick reference guide   (PDF   344.7KB)

CG28 Depression in children and young people - Full NICE guideline   (PDF format   264KB)

CG28 Depression in children and young people - Full NICE guideline   (MS Word format   768KB)


Source...   (PDF)


Related APG articles:
Abstract: SSRIs in Major Depressive Disorder in children and adolescents (ratio of benefits/risks)

Analysis confirms impact of FDA's antidepressant warning and raises concern for kids, APA says

Data Behind Antidepressant Advisory Don't Give Clear-Cut Answers

AMA Opposes Restrictions On SSRI Use In Youngsters

Abstract: Suicidality in depressive children and adolescents during treatment with SSRIs

Canadian Psychiatric Association issues position statement on antidepressants

European Union split on use of fluoxetine [Prozac] in children

What Parents Need to Know: Treating Depression in Children and Teens

FDA's Patient Representative Reverses Position On SSRI Black-Box Warning

Unraveling the jumble of data on depression, drugs, and kids

European Medicines Agency Finalises Review Of Antidepressants In Children And Adolescents

Suicide Rates Began to Drop With Advent of SSRIs

SSRI [Suicide] Data Continue To Confound Researchers

Treatment of Depression in Children Fraught With Challenges

links: digg this    del.icio.us    technorati    reddit